Fanny Lanternier1, Sophie Cypowyj, Capucine Picard, Jacinta Bustamante, Olivier Lortholary, Jean-Laurent Casanova, Anne Puel. 1. aLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U980 Necker Medical School, Imagine Institute and Paris Descartes University, Sorbonne Paris Cité bInfectious Diseases and Tropical Medicine Unit, Necker-Enfants Malades Hospital, AP-HP and Paris Descartes University cPasteur Institute, National Reference Center of Invasive Mycoses and Antifungals, Paris, France dSt Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA eStudy Center for Immunodeficiency fPediatric Hematology-Immunology Unit, Necker Enfants-Malades Hospital, AP-HP, and Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Abstract
PURPOSE OF REVIEW: We review the primary immunodeficiencies (PIDs) underlying an increasing variety of superficial and invasive fungal infections. We also stress that the occurrence of such fungal infections should lead physicians to search for the corresponding single-gene inborn errors of immunity. Finally, we suggest that other fungal infections may also result from hitherto unknown inborn errors of immunity, at least in some patients with no known risk factors. RECENT FINDINGS: An increasing number of PIDs are being shown to underlie fungal infectious diseases in children and young adults. Inborn errors of the phagocyte NADPH oxidase complex (chronic granulomatous disease), severe congenital neutropenia (SCN) and leukocyte adhesion deficiency type I confer a predisposition to invasive aspergillosis and candidiasis. More rarely, inborn errors of interferon-γ immunity underlie endemic mycoses. Inborn errors of interleukin-17 immunity have recently been shown to underlie chronic mucocutaneous candidiasis (CMC), while inborn errors of caspase recruitment domain-containing protein 9 (CARD9) immunity underlie deep dermatophytosis and invasive candidiasis. SUMMARY: CMC, invasive candidiasis, invasive aspergillosis, deep dermatophytosis, pneumocystosis, and endemic mycoses can all be caused by PIDs. Each type of infection is highly suggestive of a specific type of PID. In the absence of overt risk factors, single-gene inborn errors of immunity should be sought in children and young adults with these and other fungal diseases.
PURPOSE OF REVIEW: We review the primary immunodeficiencies (PIDs) underlying an increasing variety of superficial and invasive fungal infections. We also stress that the occurrence of such fungal infections should lead physicians to search for the corresponding single-gene inborn errors of immunity. Finally, we suggest that other fungal infections may also result from hitherto unknown inborn errors of immunity, at least in some patients with no known risk factors. RECENT FINDINGS: An increasing number of PIDs are being shown to underlie fungal infectious diseases in children and young adults. Inborn errors of the phagocyte NADPH oxidase complex (chronic granulomatous disease), severe congenital neutropenia (SCN) and leukocyte adhesion deficiency type I confer a predisposition to invasive aspergillosis and candidiasis. More rarely, inborn errors of interferon-γ immunity underlie endemic mycoses. Inborn errors of interleukin-17 immunity have recently been shown to underlie chronic mucocutaneous candidiasis (CMC), while inborn errors of caspase recruitment domain-containing protein 9 (CARD9) immunity underlie deep dermatophytosis and invasive candidiasis. SUMMARY:CMC, invasive candidiasis, invasive aspergillosis, deep dermatophytosis, pneumocystosis, and endemic mycoses can all be caused by PIDs. Each type of infection is highly suggestive of a specific type of PID. In the absence of overt risk factors, single-gene inborn errors of immunity should be sought in children and young adults with these and other fungal diseases.
Authors: Lena F Schimke; Nikolaus Rieber; Stacey Rylaarsdam; Otávio Cabral-Marques; Nicholas Hubbard; Anne Puel; Laura Kallmann; Stephanie Anover Sombke; Gundula Notheis; Hans-Peter Schwarz; Birgit Kammer; Tomas Hökfelt; Reinald Repp; Capucine Picard; Jean-Laurent Casanova; Bernd H Belohradsky; Michael H Albert; Hans D Ochs; Ellen D Renner; Troy R Torgerson Journal: J Clin Immunol Date: 2013-05-25 Impact factor: 8.317
Authors: Anete S Grumach; Flavio de Queiroz-Telles; Mélanie Migaud; Fanny Lanternier; Nelson Rosario Filho; Sandra M U Palma; Rosemeire Navickas Constantino-Silva; Jean Laurent Casanova; Anne Puel Journal: J Clin Immunol Date: 2015-06-05 Impact factor: 8.317
Authors: Ana Van Den Rym; Prasad Taur; Rubén Martinez-Barricarte; Lazaro Lorenzo; Anne Puel; Pablo Gonzalez-Navarro; Ambreen Pandrowala; Vijaya Gowri; Amin Safa; Victor Toledano; Carolina Cubillos-Zapata; Eduardo López-Collazo; Maria Vela; Antonio Pérez-Martínez; Silvia Sánchez-Ramón; Maria J Recio; Jean-Laurent Casanova; Mukesh M Desai; Rebeca Perez de Diego Journal: J Clin Immunol Date: 2020-02-01 Impact factor: 8.317
Authors: Chang Ook Park; Xiujun Fu; Xiaodong Jiang; Youdong Pan; Jessica E Teague; Nicholas Collins; Tian Tian; John T O'Malley; Ryan O Emerson; Ji Hye Kim; Yookyung Jung; Rei Watanabe; Robert C Fuhlbrigge; Francis R Carbone; Thomas Gebhardt; Rachael A Clark; Charles P Lin; Thomas S Kupper Journal: J Allergy Clin Immunol Date: 2017-11-09 Impact factor: 10.793